Citation: | Xinyi Chai, Yanqiu Gu, Lei Lv, Chun Chen, Fei Feng, Yan Cao, Yue Liu, Zhenyu Zhu, Zhanying Hong, Yifeng Chai, Xiaofei Chen. Screening of immune cell activators from Astragali Radix using a comprehensive two-dimensional NK-92MI cell membrane chromatography/C18 column/time-of-flight mass spectrometry system[J]. Journal of Pharmaceutical Analysis, 2022, 12(5): 725-732. doi: 10.1016/j.jpha.2022.05.006 |
L.B. Kennedy, A.K.S. Salama, A review of cancer immunotherapy toxicity, CA A Cancer J. Clin. 70 (2020) 86-104
|
E. Vivier, E. Tomasello, M. Baratin, et al., Functions of natural killer cells, Nat. Immunol. 9 (2008) 503-510
|
P. Kwaśnik, M.K. Lemieszek, W. Rzeski, Impact of phytochemicals and plant extracts on viability and proliferation of NK cell line NK-92 - a closer look at immunomodulatory properties of goji berries extract in human colon cancer cells, Ann. Agric. Environ. Med. 28 (2021) 291-299
|
J.A. Myers, J.S. Miller, Exploring the NK cell platform for cancer immunotherapy, Nat. Rev. Clin. Oncol. 18 (2021) 85-100
|
Z. Chen, L. Liu, C. Gao, et al., Astragali Radix (Huangqi): a promising edible immunomodulatory herbal medicine, J. Ethnopharmacol. 258 (2020), 112895
|
K. Li, Y.X. Cao, S.M Jiao, et al., Structural characterization and immune activity screening of polysaccharides with different molecular weights from Astragali Radix, Front. Pharmacol. 11 (2020), 582091
|
H. Liu, Z.-Y. Wang, Y.-C. Zhou, et al., Immunomodulation of Chinese Herbal Medicines on NK cell populations for cancer therapy: a systematic review, J. Ethnopharmacol. 268 (2021), 113561
|
R. Han, W.-Q. Wu, X.-P. Wu, et al., Effect of total flavonoids from the seeds of Astragali complanation natural killer cell function, J. Ethnopharmacol. 173 (2015) 157-165
|
W. Ma, C. Wang, R. Liu, et al., Advances in cell membrane chromatography, J. Chromatogr. A 1639 (2021), 461916
|
X. Chen, Y. Wu, C. Chen, et al., Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening, Acta Pharm. Sin. B 11 (2021) 222-236
|
Q. Hu, Y. Bu, R. Cao, et al., Stability designs of cell membrane cloaked magnetic carbon nanotubes for improved life span in screening drug leads, Anal. Chem. 91 (2019) 13062-13070
|
Y. Bu, X. Zhang, A. Zhu, et al., Inside-out-oriented cell membrane biomimetic magnetic nanoparticles for high-performance drug lead discovery, Anal. Chem. 93 (2021) 7898-7907
|
P. Pan, J. Cheng, Y. Si, et al., A stop-flow comprehensive two-dimensional HK-2 and HK-2/CIKI cell membrane chromatography comparative analysis system for screening the active ingredients from Pyrrosia calvata (Bak.) Ching against crystal-induced kidney injury, J. Pharm. Biomed. Anal. 195 (2021), 113825
|
Y. Gu, X. Chen, R. Wang, et al., Comparative two-dimensional HepG2 and L02/cell membrane chromatography/C18/time-of-flight mass spectrometry for screening selective anti-hepatoma components from Scutellariae Radix, J. Pharm. Biomed. Anal. 164 (2019) 550-556
|
Y. Gu, X. Chen, Y. Wang, et al., Development of 3-mercaptopropyltrimethoxysilane (MPTS)-modified bone marrow mononuclear cell membrane chromatography for screening anti-osteoporosis components from Scutellariae Radix, Acta Pharm. Sin. B 10 (2020) 1856-1865
|
X. Ding, Y. Cao, Y. Yuan, et al., Development of APTES-decorated HepG2 cancer stem cell membrane chromatography for screening active components from Salvia miltiorrhiza, Anal. Chem. 88 (2016) 12081-12089
|
X. Ding, X. Chen, Y. Cao, et al., Quality improvements of cell membrane chromatographic column, J. Chromatogr. A 1359 (2014) 330-335
|
X. Chen, Y. Cao, D. Lv, et al., Comprehensive two-dimensional HepG2/cell membrane chromatography/monolithic column/time-of-flight mass spectrometry system for screening anti-tumor components from herbal medicines, J. Chromatogr. A 1242 (2012) 67-74
|
X. Chen, Y. Cao, H. Zhang, et al., Comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from Acontium carmichaeli, Anal. Chem. 86 (2014) 4748-4757
|
H. Zhao, C. Wu, D. Gao, et al., Antitumor effect by hydroxyapatite nanospheres: activation of mitochondria-dependent apoptosis and negative regulation of phosphatidylinositol-3-kinase/protein kinase B pathway, ACS Nano 12 (2018) 7838-7854
|
A. Young, S.F. Ngiow, Y. Gao, et al., A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment, Cancer Res. 78 (2018) 1003-1016
|
T. Raskovalova, X. Huang, M. Sitkovsky, et al., Gs protein-coupled adenosine receptor signaling and lytic function of activated NK cells, J. Immunol. 175 (2005) 4383-4391
|
V. Beltran-Beltran, N. Benetó, T. Lapeña-Luzón, et al., Role of adenosine receptors in rare neurodegenerative diseases with motor symptoms, Curr. Protein Pept. Sci. 22 (2021) 675-694
|
N. Tripathi, N. Tripathi, M.K. Goshisht, COVID-19: inflammatory responses, structure-based drug design and potential therapeutics, Mol. Divers. 26 (2022) 629-645
|
C. Ji, Y. Luo, C. Zou, et al., Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress, BMC Pharmacol. Toxicol. 19 (2018), 53
|
H. Liu, F. Huang, H. Wu, et al., Isoastragaloside I inhibits NF-κB activation and inflammatory responses in BV-2 microglial cells stimulated with lipopolysaccharide, Int. J. Mol. Med. 40 (2017) 1270-1276
|
M. Hirotani, Y. Zhou, H. Rui, et al., Cycloartane triterpene glycosides from the hairy root cultures of Astragalus membranaceus, Phytochemistry 37 (1994) 1403-1407
|
Y. Qi, F. Gao, L. Hou, et al., Anti-inflammatory and immunostimulatory activities of astragalosides, Am. J. Chin. Med. 45 (2017) 1157-1167
|
G. Fotakis, J.A. Timbrell, In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride, Toxicol. Lett. 160 (2006) 171-177
|